In a report released yesterday, Michael Cyprys from Morgan Stanley maintained a Hold rating on Invesco (IVZ – Research Report), with a price target of $15.00.
Michael Cyprys has given his Hold rating due to a combination of factors impacting Invesco’s financial outlook. Following the first quarter of 2025 earnings, there was a downward revision in the estimated adjusted earnings per share (EPS) for the second quarter of 2025 by 8.6%, bringing it down to 37 cents from the previous estimate of 41 cents. Additionally, the full-year 2025 adjusted EPS forecast was reduced by 3.3% to $1.68.
The price target remains unchanged at $15, reflecting a valuation based on a 6.3x EBITDA multiple and an 8.3x target price-to-earnings ratio. These adjustments are influenced by a combination of factors, including competitive pressures and slightly reduced management fees. The Hold rating suggests a balanced view, indicating that while there are challenges, the stock’s current valuation does not warrant a more aggressive stance.
In another report released on April 23, Barclays also maintained a Hold rating on the stock with a $14.00 price target.
IVZ’s price has also changed moderately for the past six months – from $17.900 to $13.940, which is a -22.12% drop .